Yole: Infectious diseases will be best market for on-site diagnostics, but development will take some time still

Contributed by Frédéric Breussin, Project Manager, Microfluidics, Yole Développement Despite its exciting potential, point-of-care diagnostics has yet to develop into the big market many expected. Testing for infectious diseases now looks like the most promising markets, as companies develop more sophisticated integrated systems that go beyond simple immunoassays to molecular diagnostics at reasonable cost.

Continue reading →